Monday, September 25, 2017

Will “Interchangeability” Boost Biosimilar Prescribing?

Pharmaceutical Executive (press release) (blog)-6 hours ago
And as states govern pharmacy practice in the U.S., Cohen noted that state drug substitution laws will need to be updated to permit pharmacy-level substitution ...

No comments: